MAFEIP (assessing eHealth innovations) presented at a workshop in Girona
The MAFEIP study team conducted a workshop in order to inform potential users about the tool, its scope and functionalities, and promote its uptake by providing different support mechanisms. The workshop was held on 27th February 2017 in Gerona, Spain in the context of the final conference of EU integrated care projects CareWell and BeyondSilos. More than 20 representatives of EU organisations dealing with integrated care and other active and healthy ageing topics attended the event. They were introduced to the study and the MAFEIP tool by Francisco Lupiáñez-Villanueva and Ruth Vilar, OpenEvidence. The participants benefitted from the experience gathered by assessing a concrete fall prevention intervention presented as a case study by Dr. Leandro Pecchia, University of Warwick. Strahil Birov from empirica presented the different support mechanisms which are at the disposal of any organisation interested in using MAFEIP to assess their innovations in active and healthy ageing. An open discussion followed to allow participants to provide feedback and to better understand their needs and expectations.
The purpose of the MAFEIP tool is to estimate the health and economic outcomes of a large variety of social and technological innovations in the health and care sector relative to current care. Examples of innovative interventions include new care pathways, devices, surgical techniques, organisational models, among others.
MAFEIP indeed provides an early assessment of the likelihood that interventions will achieve the anticipated impact, and also helps to identify what drives interventions’ effectiveness or efficiency in order to guide further design, development or evaluation. At a later stage of the innovation development, MAFEIP can assess with better precision the value of the innovation for citizens and other stakeholders. MAFEIP therefore represents a clear support to the decision-making process.
The Commission does not intend to assess the incremental cost-effectiveness of an intervention carried out by an EIP on AHA commitment, nor to compare several interventions on their cost- effectiveness. Rather, the general aim of the MAFEIP study is to estimate the aggregated impact of the EIP on AHA on its overall health and health system objectives.
Organisations interested in applying MAFEIP to assess their innovations can visit the website.